Search

Addressing the bureaucracy challenge

EHA has recently brought key stakeholders around the table to discuss bureaucratic obstacles in clinical research.

Read more

Addition of obinutuzumab (GA101) or rituximab to chlorambucil improves outcomes for elderly patients with chronic lymphocytic leukemia (CLL) and co-existing medical conditions (comorbidities)

CLL is the most common leukemia in the western world. Many CLL patients are elderly and have comorbidities rendering them ineligible for aggressive standard treatments.

Read more

Registration & accommodation

Registration is closed

Individual RegistrationRegistration fee includes:

Access to the scientific and educational sessions of the meeting
Digital meeting materials including the program and abstract book
Networking opportunities during breaks, receptions and dinners
Catering during meeting hours incl.

Read more

EBAH Certified Meetings

In this page, you will find hematology-related meetings which are either EBAH-certified or from partners of EHA. You can choose to see meetings per year or category in the menus below.

Read more

EHA welcomes European Parliament backing for SoHO legislation

EHA welcomes the European Parliament’s backing for SoHO legislation that puts patient safety and supply sustainability first.

Read more

EHA2022 Gallery

Thank you to the Faculty, delegates, and industry partners for contributing to the EHA2022 Hybrid Congress.

Read more

EHA Taskforce on Diversity, Equity, and Inclusion

The Diversity, Equity, and Inclusion Taskforce has a mandate from the EHA Board to develop a policy on Diversity, Equity, and Inclusion that will be the blueprint for:

Initiating and implementing activities to empower underrepresented groups.

Read more

EHA-SWG Scientific Meetings

On this page, you can browse and/or download the interactive EHA-SWG Scientific Meetings Sponsor Program.

Read more